Secukinumab: A complete approach to psoriatic patients-Real-world evidence study
Dermatol Ther
.
2021 Mar;34(2):e14815.
doi: 10.1111/dth.14815.
Epub 2021 Feb 17.
Authors
Paulo Ferreira
1
,
Pedro Mendes-Bastos
1
Affiliation
1
Psoriasis Clinic, Dermatology Center, Hospital CUF Descobertas, Lisbon, Portugal.
PMID:
33497528
DOI:
10.1111/dth.14815
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized*
Arthritis, Psoriatic* / drug therapy
Humans
Substances
Antibodies, Monoclonal, Humanized
secukinumab